Prestige Consumer Healthcare Inc.
HealthcareNYSE:PBH · New York Stock Exchange
+$0.25 today
Vol 0.44M · Avg 0.65M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$1.1B of revenue converted into $190.3M of net income for the selected period. Gross margin is 54.0% and net margin is 17.5%, showing how much revenue survives after costs and taxes. EPS is $3.91, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B -4.3% | $1.1B +1.1% | $1.1B -0.2% | $1.1B +3.8% | $1.1B | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $514.1M +2.1% | $503.3M +0.5% | $500.9M -0.3% | $502.4M +7.8% | $466.2M | $344.8M | $725.6M | $804.0M |
| Gross Profit | $574.6M -9.4% | $634.5M +1.6% | $624.4M -0.1% | $625.3M +0.7% | $620.6M | $10.3B | $8.9B | $7.6B |
| Gross Margin | 52.8% -3.0pp | 55.8% +0.3pp | 55.5% +0.0pp | 55.4% -1.7pp | 57.1% | 45.5% | 9.8% | 28.9% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $265.2M +0.5% | $263.9M +1.7% | $259.5M +2.8% | $252.4M -4.7% | $264.8M | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $265.2M -10.9% | $297.7M +5.6% | $282.0M -56.5% | $647.7M +122.8% | $290.7M | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $31.3M +3.6% | $30.2M -1.6% | $30.7M -6.0% | $32.6M +1.7% | $32.1M | $1.2B | $374.2M | $1.2B |
| EBITDA | $331.1M -8.5% | $362.0M -3.2% | $373.9M +4648.0% | $7.9M -97.8% | $358.8M | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 30.4% -1.4pp | 31.8% -1.4pp | 33.2% +32.5pp | 0.7% -32.3pp | 33.0% | 10.0% | 5.6% | 46.3% |
| Operating Income | $309.4M -8.1% | $336.8M -1.7% | $342.4M +1627.7% | -$22.4M -106.8% | $329.9M | $10.6B | $12.3B | $14.0B |
| Operating Margin | 28.4% -1.2pp | 29.6% -0.8pp | 30.4% +32.4pp | -2.0% -32.3pp | 30.4% | 18.7% | 16.6% | 24.1% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $42.3M -11.1% | $47.6M -29.1% | $67.2M -2.9% | $69.2M +7.6% | $64.3M | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | -$51.9M +1.3% | -$52.6M +20.8% | -$66.4M +7.1% | -$71.5M -6.0% | -$67.5M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $257.5M -9.4% | $284.2M +3.0% | $276.0M +393.9% | -$93.9M -135.8% | $262.5M | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 23.7% -1.3pp | 25.0% +0.5pp | 24.5% +32.9pp | -8.3% -32.5pp | 24.1% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $67.2M -3.4% | $69.6M +4.3% | $66.7M +674.4% | -$11.6M -120.3% | $57.1M | $666.8M | $1.3B | -$1.6B |
| Net Income | $190.3M -11.3% | $214.6M +2.5% | $209.3M +354.3% | -$82.3M -140.1% | $205.4M | $5.0B | $4.9B | $4.8B |
| Net Margin | 17.5% -1.4pp | 18.9% +0.3pp | 18.6% +25.9pp | -7.3% -26.2pp | 18.9% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $4 -9.0% | $4 +2.6% | $4 +355.2% | -$2 -140.3% | $4 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $4 -8.9% | $4 +2.9% | $4 +352.7% | -$2 -140.8% | $4 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $48.5M -2.5% | $49.7M -0.1% | $49.8M -0.3% | $49.9M -0.7% | $50.3M | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $48.7M -2.7% | $50.1M -0.2% | $50.2M +0.6% | $49.9M -1.9% | $50.8M | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$6.63B
LivaNova PLC
NASDAQ:LIVN
$4.36B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.60B
ICU Medical, Inc.
NASDAQ:ICUI
$3.55B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.95B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.87B
Disc Medicine, Inc.
NASDAQ:IRON
$2.60B
Zai Lab Limited
NASDAQ:ZLAB
$1.92B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.27B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does PBH generate?
Prestige Consumer Healthcare Inc. (PBH) reported $1.09B of revenue in fiscal 2026.
Is PBH profitable?
Prestige Consumer Healthcare Inc. (PBH) reported $190.30M of net income, with a net margin of 17.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.